Amicus Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 14.49 USD (At close: Apr 24, 2026) · Market cap 4.55B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company’s commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease; and DMX-200, a small molecu...